A significant distinction resides in the severity of the disease: the population of the DANISH study consisted predominantly of outpatients who were in stable condition, while the patients in our study were patients with severe symptomatic heart failure, including ambulatory Class IV NYHA (CRT-recipients), with a median NT-proBNP of 1698 pg/mL. The gene discussed is NPPB; the disease is heart failure.